International Health Policy Program, Ministry of Public Health, Soi Satharanasook 6, Tiwanon Road, Nonthaburi 11000, Thailand.
Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand.
Bull World Health Organ. 2017 Aug 1;95(8):599-603. doi: 10.2471/BLT.16.179648. Epub 2017 May 11.
In Thailand, antimicrobial resistance has formed a small component of national drug policies and strategies on emerging infectious diseases. However, poor coordination and a lack of national goals and monitoring and evaluation platforms have reduced the effectiveness of the corresponding national actions.
On the basis of local evidence and with the strong participation of relevant stakeholders, the first national strategic plan on antimicrobial resistance has been developed in Thailand.
Before the development of the plan, ineffective coordination meant that antimicrobial resistance profiles produced at sentinel hospitals were not used effectively for clinical decision-making. There was no integrated system for the surveillance of antimicrobial resistance, no system for monitoring consumption of antimicrobial drugs by humans, livestock and pets and little public awareness of antimicrobial resistance.
In August 2016, the Thai government endorsed a national strategic plan on antimicrobial resistance that comprised six strategic actions and five targets. A national steering committee guides the plan's implementation and a module to assess the prevalence of household antibiotic use and antimicrobial resistance awareness has been embedded into the biennial national health survey. A national system for the surveillance of antimicrobial consumption has also been initiated.
Strong political commitment, national ownership and adequate multisectoral institutional capacities will be essential for the effective implementation of the national plan. A robust monitoring and evaluation platform now contributes to evidence-based interventions. An integrated system for the surveillance of antimicrobial resistance still needs to be established.
在泰国，抗菌药物耐药性已成为新兴传染病国家药物政策和战略的一小部分。然而，协调不力以及缺乏国家目标和监测及评价平台，降低了相应国家行动的效力。
在当地证据的基础上，并在相关利益攸关方的大力参与下，泰国制定了首个国家抗菌药物耐药性战略计划。
在制定该计划之前，协调不力意味着在哨点医院产生的抗菌药物耐药性概况不能有效用于临床决策。没有用于监测抗菌药物耐药性的综合系统，没有监测人类、家畜和宠物使用抗菌药物情况的系统，公众对抗菌药物耐药性的认识也有限。
2016 年 8 月，泰国政府批准了一项国家抗菌药物耐药性战略计划，该计划包括六项战略行动和五个具体目标。一个国家指导委员会指导该计划的实施，一个评估家庭抗生素使用情况和抗菌药物耐药性意识的模块已被纳入两年一次的国家卫生调查。还启动了一个国家抗菌药物消费监测系统。
强有力的政治承诺、国家自主权和充分的多部门机构能力对于国家计划的有效实施至关重要。一个健全的监测和评价平台现在有助于采取循证干预措施。仍需建立一个综合的抗菌药物耐药性监测系统。
